![](/img/cover-not-exists.png)
2137 Comparison of two Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver only metastases
Oki, E., Emi, Y., Miyamoto, Y., Ogata, Y., Tokunaga, S., Shirabe, K., Beppu, T., Uchida, S., Takatsuki, M., Sakoda, M., Eguchi, S., Akagi, Y., Kakeji, Y., Baba, H., Natsugoe, S., Maehara, Y.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31058-9
Date:
September, 2015
File:
PDF, 63 KB
english, 2015